Showing 1381-1390 of 7002 results for "".
Gender Bias and Heart Health: Improving Cardiovascular Care for Women
https://reachmd.com/programs/heart-matters/gender-bias-and-heart-health-improving-cardiovascular-care-for-women/37856/Cardiovascular disease is the leading cause of mortality in women, yet it is often underrecognized due to gender bias in healthcare. Hear from Dr. Connie Newman as she explores the impact of bias on cardiovascular risk perception, highlights the importance of lipid and Lp(a) screening, and reviews eShared Goals, Shared Gains: Align With Patient Preferences
https://reachmd.com/programs/cme/shared-goals-shared-gains-align-with-patient-preferences/54776/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists
https://reachmd.com/programs/cme/building-bridges-closing-gaps-in-nash-care-the-pivotal-role-of-gastroenterologists/15671/Are you up to date on the NAFLD clinical care pathway to provide optimal treatment for your patients?Clinical Perspective on New Therapies in Resistant Hypertension
https://reachmd.com/clinical-practice/cardiology/clinical-perspective-on-new-therapies-in-resistant-hypertension/48895/How can we best address resistant hypertension in today’s world? New agents address a critical unmet need, and Dr. Yancy has what you need to know.Genetic Testing Among Women with Breast Cancer Increasing, Can Impact Treatment Decisions
https://reachmd.com/programs/the-jama-report/genetic-testing-among-women-breast-cancer-increasing-can-impact-treatment-decisions/7935/[Read the Article] Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testingStemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
https://reachmd.com/programs/cme/stemming-the-tide-on-masldmash-it-starts-on-the-frontlines-in-endocrinology-and-primary-care-clinics/35568/Join us for a broadcast replay from Global Fatty Liver Day to learn more about cardiometabolic risk factors and improve your care of patients with MASLD/MASH.Pioneering a First in Robotic Liver Transplant
https://reachmd.com/programs/medical-industry-feature/pioneering-a-first-in-robotic-liver-transplant/29920/Learn more about the innovations that led to the first fully robotic liver transplant in New York and how it is transforming the future of surgery.Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
https://reachmd.com/programs/cme/real-world-igan-a-case-based-approach-to-maximizing-kidney-preservation/26635/Are you implementing the new KDIGO guidelines for IgA nephropathy? Learn how to apply them in clinical practice using a real-world patient case.Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
https://reachmd.com/programs/cme/subtle-vs-syndromic-distinguishing-td-from-other-dimds-in-the-neuro-clinic/56642/Improve your diagnostic and screening skills for tardive dyskinesia and learn about the important role of VMAT2 inhibitors in the management of this disorder.Target Locked in gMG: Why T2T Matters
https://reachmd.com/programs/cme/target-locked-in-gmg-why-t2t-matters/54768/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.